Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

References

• SunJLiuWAdamsTSDNA copy number alterations in prostate cancers: a combined analysis of published CGH studiesProstate200767769270017342750
   PubMed Web of Science ®Google Scholar
• TaylorBSSchultzNHieronymusHIntegrative genomic profiling of human prostate cancerCancer Cell2010181112220579941
   PubMed Web of Science ®Google Scholar
• WeischenfeldtJSimonRFeuerbachLIntegrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerCancer Cell201323215917023410972
   PubMed Web of Science ®Google Scholar
• HuangSGulzarZGSalariKLapointeJBrooksJDPollackJRRecurrent deletion of CHD1 in prostate cancer with relevance to cell invasivenessOncogene201231374164417022179824
   PubMed Web of Science ®Google Scholar
• KrohnASeidelABurkhardtLRecurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersJ Pathol2013231113014123794398
   PubMed Web of Science ®Google Scholar
• MaoXBoydLKYáñez-MuñozRJChromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancerAm J Cancer Res20111560461721994901
   PubMed Web of Science ®Google Scholar
• WiseHMHermidaMALeslieNRProstate cancer, PI3K, PTEN and prognosisClin Sci2017131319721028057891
   PubMed Web of Science ®Google Scholar
• MinnerSGärtnerMFreudenthalerFMarked heterogeneity of ERG expression in large primary prostate cancersMod Pathol201326110611622899295
   PubMed Web of Science ®Google Scholar
• KluthMJungSHabibODeletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancerOncotarget201786510892310893529312579
   PubMedGoogle Scholar
• KrohnAFreudenthalerFHarasimowiczSHeterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancerMod Pathol201427121612162024762546
   PubMed Web of Science ®Google Scholar
• KluthMMeyerDKrohnAHeterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerOncotarget2016743897390426684029
   PubMedGoogle Scholar
• McnealJERedwineEAFreihaFSStameyTAZonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spreadAm J Surg Pathol198812128979063202246
   PubMed Web of Science ®Google Scholar
• ErbersdoblerAHammererPHulandHHenkeRPNumerical chromosomal aberrations in transition-zone carcinomas of the prostateJ Urol19971584159415989302180
   PubMed Web of Science ®Google Scholar
• WiseAMStameyTAMcnealJEClaytonJLMorphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimensUrology200260226426912137824
   PubMed Web of Science ®Google Scholar
• MinnerSEnodienMSirmaHERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of anti-hormonal therapyClin Cancer Res201117185878588821791629
   PubMed Web of Science ®Google Scholar
• KrohnADiedlerTBurkhardtLGenomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAm J Pathol2012181240141222705054
   PubMed Web of Science ®Google Scholar
• PernerSMosqueraJMDemichelisFTMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasionAm J Surg Pathol200731688288817527075
   PubMed Web of Science ®Google Scholar
• SchaeferGMosqueraJMRamonerRDistinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancerProstate Cancer Prostatic Dis201316213213823381693
   PubMed Web of Science ®Google Scholar
• TsourlakisMCStenderAQuaasAHeterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patientsBMC Cancer20161664127530104
   PubMed Web of Science ®Google Scholar
• MertzKDHorcicMHailemariamSHeterogeneity of ERG expression in core needle biopsies of patients with early prostate cancerHum Pathol201344122727273524074533
   PubMed Web of Science ®Google Scholar
• GabutMSamavarchi-TehraniPWangXAn alternative splicing switch regulates embryonic stem cell pluripotency and reprogrammingCell2011147113214621924763
   PubMed Web of Science ®Google Scholar
• BraseJCJohannesMMannspergerHTMPRSS2-ERG-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingBMC Cancer20111150722142399
   PubMed Web of Science ®Google Scholar
• TomlinsSARhodesDRYuJThe role of SPINK1 in ETS rearrangement-negative prostate cancersCancer Cell200813651952818538735
   PubMed Web of Science ®Google Scholar
• SchlisioSHalperinTVidalMNevinsJRInteraction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F functionEmbo J200221215775578612411495
   PubMed Web of Science ®Google Scholar
• BockJMochmannLHSchleeCERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signalingPLoS One201381e5287223300998
   PubMed Web of Science ®Google Scholar
• HalacliSODoganALFOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cellsOncol Lett2015931482148825663935
   PubMed Web of Science ®Google Scholar
• TakayamaKSuzukiTTsutsumiSIntegrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancerMol Endocrinol201428122012202425329375
   PubMedGoogle Scholar
• BilkeSSchwentnerRYangFOncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancerGenome Res201323111797180923940108
   PubMed Web of Science ®Google Scholar
• CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
   PubMed Web of Science ®Google Scholar
• GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269pl123550210
   PubMed Web of Science ®Google Scholar
• NijhawanDZackTIRenYCancer vulnerabilities unveiled by genomic lossCell2012150484285422901813
   PubMed Web of Science ®Google Scholar
• HannaWNofech-MozesSKahnHJIntratumoral heterogeneity of HER2/neu in breast cancer–a rare eventBreast J200713212212917319852
   PubMed Web of Science ®Google Scholar
• de WinterJATrapmanJBrinkmannAOAndrogen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistryJ Pathol199016043293322193135
   PubMed Web of Science ®Google Scholar
• RubinMADunnRStrawdermanMPientaKJTissue microarray sampling strategy for prostate cancer biomarker analysisAm J Surg Pathol200226331231911859202
   PubMed Web of Science ®Google Scholar
• KristiansenGFritzscheFRWassermannKGOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnosticsBr J Cancer200899693994818781151
   PubMed Web of Science ®Google Scholar